HudsonAlpha associate company Kailos Genetics announced today a new partnership with In-Q-Tel, Inc. (IQT) to further develop leading-edge next-generation sequencing solutions for the intelligence community.
IQT is the non-profit strategic investor that identifies and accelerates the development of innovative technologies to support the mission of the U.S. Intelligence Community.
Read the full release from Kailos.
